SIGA Technologies Inc (SIGA): Koefisien rega marang pendapatan

Simbol lan logo merek TPOXX (SIGA)

SIGA Technologies, Inc. (SIGA) products in the commercial growth phase provide biodefense through multi-year government contracts. The company's P/S chart visualizes the asset's overheating, where the 3.70 mark indicates the market capitalization-to-revenue valuation level. The business relies on a supply monopoly of TPOXX for NATO and the US, generating revenue from procurement by various countries' ministries of health to build strategic stockpiles.

SIGA Technologies, Inc. (SIGA): Multiplikator P/S saka 04.07.2022 nganti 14.11.2026

SIGA Corp (SIGA) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:
Bagan bursa siga.com|SIGA - Bagan rega target
- data kapitalisasi bursa:
Kapitalisasi pasar SIGA Corp|SIGA - Nilai Perusahaan
- rincian nilai buku perusahaan:
Aset Bersih saben Saham SIGA Technologies|SIGA - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas siga.com|SIGA - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal SIGA Technologies, Inc.|SIGA - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal TPOXX|SIGA - Gunggung utang perusahaan|Utang marang modal buku SIGA Corp|SIGA - Utang jangka dawa perusahaan|Utang jangka cendhak SIGA Technologies|Indikator likuiditas cepet siga.com
- data bathi resik lan rasio valuasi:
SIGA - Bathi resik|Penghasilan resik sing dikarepake SIGA Technologies, Inc.|SIGA - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep SIGA Technologies Inc|SIGA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan SIGA Corp|SIGA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan SIGA Technologies|SIGA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan siga.com|SIGA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep SIGA Technologies, Inc.
- rincian pendapatan lan dodolan emiten:
SIGA - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan siga.com|SIGA - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SIGA Corp
Ringkesan analitik perusahaan:siga.com
Produk mawa merek TPOXX

The P/S multiple determines the market value of one dollar of revenue, allowing an investor to assess the premium paid for the business's current sales volume. For SIGA Technologies, Inc. (SIGA), which is scaling deliveries to government stockpiles and expanding its drug portfolio, the company's average P/S reflects market expectations for future revenue diversification, helping to determine whether the capitalization is fair relative to operational successes.

Perusahaan pesaing

Koefisien rega marang pendapatan gilead.com|Rasio rega marang pendapatan Cidara Therapeutics Inc CDTX|Koefisien rega marang pendapatan Novavax Inc (NVAX)|CureVac Corp - Multiplikator P/S|Koefisien rega marang pendapatan Valneva Vaccines VALN|VIR: Multiplikator P/S|Multiplikator rega marang pendapatan emergentbiosolutions.com EBS|AVIR (Atea Pharmaceuticals, Inc.) - Multiplikator P/S|Multiplikator P/S Invivyd Corp|Kapitalisasi marang pendapatan ENTA (Enanta)|INO (Inovio Pharma) - Rasio kapitalisasi pasar marang pendapatan|HilleVax, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan KLRS (kalaristx.com)|Dyadic - Multiplikator P/S|Rega marang dodolan NanoViricides, Inc.|TLPH: Multiplikator P/S|Kapitalisasi marang pendapatan Cocrystal Pharma Corp|TRAW (Traws Pharma Inc) - Multiplikator P/S|DWTX: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Qualigen Therapeutics, Inc. (QLGN)|allovir.com - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan VBI Vaccines VBIV|Virios Therapeutics Inc. (VIRI) - Rega marang dodolan|VXRT - Rasio rega marang pendapatan